510(k) device
microTargeting Guideline 4000 5.0 System
FHC, Inc. · Electrode, Depth (GZL, Class II) · First FDA decision Jul 25, 2007, newest Dec 20, 2018Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "microTargeting Guideline 4000"
MAUDE reports
6
Brand "microTargeting Guideline 4000", since 2015
PubMed studies
0
Mentioning "microTargeting Guideline 4000"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing microTargeting Guideline 4000 5.0 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K183123 · Decided Dec 20, 2018 · 37 days after receipt
Device type: Electrode, Depth (GZL) · Neurology & Neurosurgery
- MICROTARGETING GUIDELINE 4000Third-party review510(k)
K071364 · Decided Jul 25, 2007 · 70 days after receipt
Device type: Electrode, Depth (GZL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Stereotaxic Depth Electrode ImplantationNational determinationOn the books160.5Updated Apr 20, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "microTargeting Guideline 4000", any status and sponsor, newest update first.
No registered device study names "microTargeting Guideline 4000".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "microTargeting Guideline 4000", and for the whole product code for context.
This brand
6 reports: 4 malfunction, 2 injury, 0 death
Whole product code GZL
158 reports: 108 malfunction, 46 injury, 2 death
Newest reports for this brand
- MICROTARGETING GUIDELINE 4000 LP+Malfunction
24079194 · Received Jan 15, 2026 · Event dated Dec 2, 2025
Device type: Electrode, Depth (GZL)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3002250546-2024-00002 · Received Jul 3, 2024 · Event dated May 1, 2024
Device type: Electrode, Depth (GZL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Convulsion/Seizure
- MICROTARGETING¿ GUIDELINE 4000¿ 5.0 SYSTEMMalfunction
3002250546-2024-00001 · Received Mar 11, 2024 · Event dated Feb 9, 2024
Device type: Electrode, Depth (GZL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cramp(s) /Muscle Spasm(s)
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2540-2020 · Started Jun 17, 2020
Reason given: An electrical sub-circuit was not properly connected. Its purpose is to eliminate the possibility of interference with proper performance of the Guideline 5 Main Processing Unit, if an ESD event (greater than 6kV) were to occur.
Cause as FDA categorized it: Component change control · Device type: Electrode, Depth (GZL)
Z-1143-2010 · Started Dec 28, 2009 · Posted by FDA Mar 16, 2010
Reason given: The raster tab for the GL4K version 1.4 software may assign incorrect depths for waveform recordings and if used to identify the implantation target for the DBS lead, the implant may be placed in the wrong location.
Cause as FDA categorized it: Software change control · Device type: Electrode, Depth (GZL)
Published research
The most relevant PubMed records for "microTargeting Guideline 4000"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code GZL.
- Neuro Omega SystemAlpha Omega Engineering , Ltd. · 510(k) 2025
- Evo® sEEG SystemNeuroone Medical Technologies Corp. · 510(k) 2022
- Depth ElectrodesAd-Tech Medical Instrument Corporation · 510(k) 2017
- Wovyn Depth ElectrodeSensomedical Labs, Ltd. · 510(k) 2026
- Depth Electrode (RSDE-08)Beijing Sinovation Medical Technology Co., Ltd. · 510(k) 2025
- Anchor Bolts as Accessories to Depth ElectrodesAd-Tech Medical Instrument Corporation · 510(k) 2023
- Spencer Probe Depth ElectrodesAd-Tech Medical Instrument Corporation · 510(k) 2023
- SENSOSEEG Depth ElectrodesSensomedical Labs, Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.